Guan-hua Su

Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

A Dynamic Contrast-Enhanced MRI-Based Vision Transformer Model for Distinguishing HER2-Zero, -Low, and -Positive Expression in Breast Cancer and Exploring Model Interpretability.

A Dynamic Contrast-Enhanced MRI-Based Vision Transformer Model for Distinguishing HER2-Zero, -Low, and -Positive Expression in Breast Cancer and Exploring Model Interpretability.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 05, 2025

Radiomics in breast cancer: Current advances and future directions.

Radiomics in breast cancer: Current advances and future directions.

Journal: Cell reports. Medicine
Published: May 11, 2024

Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection.

Multicenter radio-multiomic analysis for predicting breast cancer outcome and unravelling imaging-biological connection.

Journal: NPJ precision oncology
Published: February 25, 2024

Decoding Intratumoral Heterogeneity: Clinical Potential of Habitat Imaging based on Radiomics.

Decoding Intratumoral Heterogeneity: Clinical Potential of Habitat Imaging based on Radiomics.

Journal: Radiology
Published: December 12, 2023

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets.

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets.

Journal: Science advances
Published: October 06, 2023

Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR+/HER2- breast cancer.

Prediction of clinicopathological features, multi-omics events and prognosis based on digital pathology and deep learning in HR+/HER2- breast cancer.

Journal: Journal of thoracic disease
Published: March 21, 2023

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology.

Uncovering the molecular subtypes of triple-negative breast cancer with a noninvasive radiomic methodology.

Journal: Cell reports. Medicine
Published: December 21, 2022

Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.

Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities.

Journal: Nature cancer
Published: December 02, 2022

ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study.

ASO Author Reflections: Deeper Insight into Therapeutic Implications and Non-invasive Detection of Homologous Recombination Deficiency in Triple-Negative Breast Cancer: Results from a Multi-omics Cohort Study.

Journal: Annals of surgical oncology
Published: April 27, 2022

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.

Radiomics features for assessing tumor-infiltrating lymphocytes correlate with molecular traits of triple-negative breast cancer.

Journal: Journal of translational medicine
Published: February 23, 2022

A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.

A Multiomics Signature Highlights Alterations Underlying Homologous Recombination Deficiency in Triple-Negative Breast Cancer.

Journal: Annals of surgical oncology
Published: February 10, 2022

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer.

Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer.

Journal: Cell reports. Medicine
Published: January 03, 2022
Showing 1-12 of 13

Last Updated: 09/26/2026